Originally written on 5thRound.com  |  Last updated 2/6/13
5d
Despite what the rumor mill had suggested over the weekend, Vitor Belfort (Pictured) did not flunk his “UFC on FX 7” drug test. We all now know Thiago Tavares is the guilty party. However, that doesn’t mean Belfort escaped the MMA headlines. The UFC has confirmed the 35-year-old received a therapeutic-use exemption (TUE) for testosterone replacement therapy (TRT) in his TKO victory over Michael Bisping. “Belfort has been on a medically approved testosterone replacement therapy (TRT) regimen under the supervision of a medical doctor from the State of Nevada, after being diagnosed with hypogonadism, or low testosterone,” the UFC expressed in their official statement. “The purpose of a medically administered TRT regimen is to allow patients with hypogonadism to maintain testosterone levels within a range that is normal for an adult male.” This explains why Belfort sidestepped the TRT question prior to his bout with Bisping. The promotion didn’t reveal how long Belfort has been on the controversial treatment. An unnamed fighter was granted a TUE for TRT at UFC 152, the same September night Belfort lost to light heavyweight king Jon Jones. The reason why most aren’t on board with TRT is simple – it’s seen as circumventing the system to get prescribed a legal performance-enhancing drug. The cheater’s handbook for TRT suggests athletes are manipulating the regimen while preparing for a fight. They will jack up their testosterone levels beyond normal ranges in order to push their bodies to its outermost limit. As showtime steadily approaches, they will then taper off the treatment to get their testosterone back to a natural level – therefore, no flunked drug tests. Because MMA organizations and athletic commissions (except Nevada) don’t conduct random, out-of-competition exams, there’s no way to police TRT use – or any performance-enhancing substances, for that matter. Belfort tested positive for elevated levels of testosterone in 2006.
GET THE YARDBARKER APP:
Ios_download En_app_rgb_wo_45
MORE FROM YARDBARKER

Cam Newton addresses ‘gang’ photo on Instagram

Steelers defense is younger and faster but not better

Duke basketball to visit White House next Tuesday

Report: Cowboys have interest in Broncos RB Montee Ball

NFL owners to discuss changing Goodell's disciplinary role

Report: Eagles trade Matt Barkley to Arizona Cardinals

LIKE WHAT YOU SEE?
GET THE DAILY NEWSLETTER:

Bill Belichick on having Tom Brady back: ‘He never left’

Mendoza replaces Schilling on 'Sunday Night Baseball'

Report: LeBron expanding program to help adults get GEDs

Here's Johnny 2.0

Michigan remains a fixer-upper in wake of loss to Utah

Tom Brady Sr. happy 'Kangaroo Court' no longer in session

MMA News
Delivered to your inbox
You'll also receive Yardbarker's daily Top 10, featuring the best sports stories from around the web. Customize your newsletter to get articles on your favorite sports and teams. And the best part? It's free!

By clicking "Sign Me Up", you have read and agreed to the Fox Sports Digital Privacy Policy and Terms of Use. You can opt out at any time. For more information, please see our Privacy Policy.
the YARDBARKER app
Get it now!
Ios_download En_app_rgb_wo_45

Robert Griffin III and a dream deferred

Best, worst surprises of NFL preseason

The Gospel Of Harbaugh prepares for its ultimate test of faith

Meet the Utah Utes, the pluckiest program in college football

Iman Shumpert will name daughter Iman Shumpert Jr.

Dallas company celebrates Romo with DirecTV 'crownies'

Top 10 storylines for Week 4 of the NFL preseason

Matt Williams is still hopelessly married to the idea of the closer’s role

Five unique CFB games to watch this weekend

Be careful what you wish for, Jay Gruden

Today's Best Stuff
For Publishers
Company Info
Help
Follow Yardbarker